PNC-27 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
PNC-27 is administered via local application (proposed: nebulizer, suppository, IV at tumor site) at >10 mcg/mL (in vitro effective concentration); clinical dosing not established not established for human use. Subcutaneous injections into the abdominal fat or thigh are most common. Proper reconstitution with bacteriostatic water is required first.
How Do You Inject PNC-27?
PNC-27 is administered via local application (proposed: nebulizer, suppository, IV at tumor site). For most researchers, subcutaneous injection is the standard approach — it's simple, relatively painless, and effective for Cell-penetrating therapeutic peptide compounds.
This guide covers injection technique, site selection, needle choices, and common mistakes.
How Do You Prepare for a PNC-27 Injection?
Step 1: Wash your hands thoroughly.
Step 2: Clean the top of the PNC-27 vial and BAC water vial with alcohol swabs. If not yet reconstituted, see our PNC-27 reconstitution guide.
Step 3: Draw your dose (>10 mcg/mL (in vitro effective concentration); clinical dosing not established) into an insulin syringe. Use our calculator for exact units.
Step 4: Clean the injection site with an alcohol swab and let it dry.
What Is the Correct Injection Technique?
Subcutaneous (most common): Pinch a fold of skin — typically abdominal fat 2+ inches from the navel, or the thigh. Insert the needle at a 45-degree angle. Push the plunger slowly and steadily. Hold for 5 seconds, then withdraw.
Intramuscular (less common for PNC-27): Insert the needle at 90 degrees into the muscle (deltoid or vastus lateralis). This route provides faster absorption but isn't necessary for most peptide protocols.
Rotate injection sites to prevent lipodystrophy (fat tissue changes from repeated injections in the same spot).
What Size Needle Should You Use?
For subcutaneous PNC-27 injections, 29-31 gauge insulin needles (½ inch or 8mm) are standard. These are thin enough to be nearly painless while long enough for proper subcutaneous delivery.
Use a fresh needle for every injection. Never reuse or share needles.
Calculate Your PNC-27 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for PNC-27.
Open Calculator →What Are Common Injection Side Effects?
Mild redness, swelling, or itching at the injection site is normal and typically resolves within hours. Small bruises can occur, especially if you hit a capillary.
If you experience persistent pain, swelling, warmth, or redness lasting more than 24 hours, discontinue and consult a healthcare provider — these may indicate infection.
Bottom Line on PNC-27 Injection
PNC-27 is administered via local application (proposed: nebulizer, suppository, IV at tumor site) at >10 mcg/mL (in vitro effective concentration); clinical dosing not established not established for human use. Subcutaneous injection with a 29-31 gauge insulin needle into abdominal fat is the standard technique. Rotate sites and use a fresh needle every time.
Complete Guide
PNC-27 : Benefits, Dosage, Side Effects & Research
Related Reading
- PNC-27 Dosage Guide
- PNC-27 Benefits
- PNC-27 Side Effects
- PNC-27 Stacking Guide
- PNC-27 Cycle Guide
- PNC-27 Research
Research-Grade Sourcing
If you're going to research PNC-27, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is PNC-27?
PNC-27 (PNC-27 (p53-penetratin chimeric peptide)) is a Cell-penetrating therapeutic peptide. 32-residue chimeric peptide combining an HDM-2 binding domain from p53 with a cell-penetrating penetratin sequence. It is researched for broad-spectrum cancer cell killing, p53-independent mechanism, minimal normal cell toxicity, rapid killing kinetics (90 minutes).
What is the recommended PNC-27 dosage?
Common dosages: >10 mcg/mL (in vitro effective concentration); clinical dosing not established administered not established for human use via local application (proposed: nebulizer, suppository, IV at tumor site). Cycle length: unknown; 90-minute killing kinetics in vitro. Half-life: not established. Use our peptide calculator for exact reconstitution math.
What are the side effects of PNC-27?
Limited safety data. No apparent toxicity to normal tissue in culture. Potential immune responses to foreign peptide.
Is PNC-27 safe?
PNC-27 has shown a preliminary safety profile in research. Not FDA-approved in USA. Clinical trials conducted internationally. Research use only in US. All research should follow appropriate safety protocols.